The aggregation of tau protein, particularly that which is heavily post-translationally modified, is an important contributor to many neurodegenerative diseases, including AD, Frontotemporal dementia (FTLD), Progressive supranuclear palsy (PSP), Pick’s Disease, and Parkinson’s disease. This evidence concerns the gene MAPT and Alzheimer disease.